|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0562 | ED148400 | General Research Use | No | Female | White | 61 | 6 - AREDS AMD Severity Scale Step 6 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0699 | ED149860 | General Research Use | No | Male | Black or African American | 61 | 7 - AREDS AMD Severity Scale Step 7 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_0971 | ED148818 | Eye Disease Only | No | Female | White | 64 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1066 | ED148882 | General Research Use | No | Male | White | 60 | 6 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_1889 | ED148324 | General Research Use | No | Female | White | 61 | 7 - AREDS AMD Severity Scale Step 7 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_2831 | ED149285 | General Research Use | No | Male | White | 63 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3256 | ED148493 | General Research Use | No | Female | Black or African American | 62 | 1 - AREDS AMD Severity Scale Step 1 | 3 - AREDS AMD Severity Scale Step 3 |
| AR2_4229 | ED149984 | General Research Use | Yes | Male | White | 64 | | |
| AR2_0419 | ED148506 | General Research Use | No | Female | White | 62 | 8 - AREDS AMD Severity Scale Step 7 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_1311 | ED148140 | General Research Use | No | Female | Black or African American | 62 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1379 | ED149312 | General Research Use | No | Male | White | 63 | 8 - AREDS AMD Severity Scale Step 8 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_1787 | ED149769 | General Research Use | No | Female | White | 61 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2216 | ED148428 | General Research Use | No | Female | White | 63 | 6 - AREDS AMD Severity Scale Step 6 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_2459 | ED148274 | General Research Use | No | Female | White | 64 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2596 | ED148271 | General Research Use | No | Male | White | 62 | 9 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2990 | ED149543 | General Research Use | No | Female | White | 60 | 4 - AREDS AMD Severity Scale Step 3 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_3260 | ED149398 | General Research Use | No | Female | White | 63 | 6 - AREDS AMD Severity Scale Step 6 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3368 | ED149332 | General Research Use | No | Female | Black or African American | 64 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3449 | ED148491 | General Research Use | No | Female | White | 62 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_3660 | ED149711 | General Research Use | No | Male | White | 63 | 5 - AREDS AMD Severity Scale Step 4 | 6 - AREDS AMD Severity Scale Step 6 |